Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FEHBP Premium "Call Letter" To Kick Off Hill Debate On Employee Program

Executive Summary

The role of pharmaceutical prices in the cost of the Federal Employees Health Benefit Program will return as a Capitol Hill issue following the release of the Office of Personnel Management's annual "call letter" on FEHBP premiums in early April.

You may also be interested in...



State Block Grants Possible in 2002 If Medicare Reform Fails This Year - Tauzin

Congress will consider a state block grant drug benefit in 2002 if a Medicare reform package does not pass this year, House Energy & Commerce Committee Chairman Tauzin (R-La.) predicted during a March 22 media briefing.

State Block Grants Possible in 2002 If Medicare Reform Fails This Year - Tauzin

Congress will consider a state block grant drug benefit in 2002 if a Medicare reform package does not pass this year, House Energy & Commerce Committee Chairman Tauzin (R-La.) predicted during a March 22 media briefing.

Medicare "Surplus" Should Not Cloud Reform - OMB Nominee Daniels

An appreciation of the serious financial challenges facing Medicare is important to preserve a political environment favorable to reform proposals, Office of Management & Budget Director-designate Mitch Daniels told the Senate Governmental Affairs Committee during his Jan. 19 confirmation hearing.

Related Content

UsernamePublicRestriction

Register

PS037545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel